Tag: clinical development productivity

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Cancer Therapy Industry By The Forecast Year 2029?

The cancer therapy market size has experienced rapid expansion in recent years. It is projected to increase from $190.44 billion in 2024 to $210.44 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.5%. The historical growth of this market stems from factors such as the increasing global incidence of cancer, the rising acceptance of chemotherapy treatments, heightened awareness regarding early cancer diagnosis, an increase in the availability of oncology specialists, and improved access to hospital-based treatment services.

The cancer therapy market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $310.85 billion by 2029, showing a compound annual growth rate (CAGR) of 10.2%. This expansion during the projection period stems from factors such as increasing demand for tailored cancer treatments, a heightened emphasis on outpatient cancer services, the growing embrace of immunotherapy, broadened healthcare access in developing nations, and the rising prevalence of cancers linked to lifestyle choices. Key trends anticipated for this period encompass technological progress in cancer diagnosis, breakthroughs in targeted medication delivery, significant investment in the research and development of biologics, the creation of AI-driven treatment strategies, and advancements in less invasive cancer surgical procedures.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24492&type=smp

Which Drivers Are Supporting Growth Of The Cancer Therapy Market?

The increasing occurrence of cancer is projected to stimulate expansion in the cancer therapy market going forward. Cancer encompasses a collection of illnesses defined by the unchecked proliferation and dissemination of atypical cells throughout the body. The uptick in cancer cases is largely attributable to greater exposure to environmental cancer-causing agents like pollution and tobacco smoke. Critical for addressing the growing incidence of cancer, cancer therapy involves treating existing patients, enhancing survival outcomes, and slowing the disease’s advancement. For example, data from February 2024 released by the World Health Organization (WHO), an intergovernmental body based in Switzerland, predicts that worldwide cancer cases will surpass 35 million annually by 2050. This signifies a 77% surge compared to the approximately 20 million cases documented in 2022. Consequently, the growing frequency of cancer is a primary catalyst for the cancer therapy market.

Which Key Segments Fueling The Cancer Therapy Market?

The cancer therapy market covered in this report is segmented –

1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types

2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types

3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers

Subsegment:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs

2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents

3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies

4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)

5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy

What Are The Latest Industry Trends Transforming The Cancer Therapy Market?

Leading companies in the cancer therapy market are concentrating on developing novel therapies, such as immuno-oncology drugs, to improve treatment effectiveness by utilizing the body’s immune system to target and destroy cancer cells. Immuno-oncology drugs are a type of cancer treatment that stimulates or enhances the body’s own immune system to more effectively recognize and attack cancer cells. For example, in December 2024, Dr. Reddy’s Laboratories Ltd., an India-based pharmaceutical company, launched Toripalimab in India; this is the first and only immuno-oncology medication approved for treating nasopharyngeal cancer. This launch offers a new, targeted treatment choice for patients suffering from this rare and aggressive cancer, potentially leading to better outcomes through advanced immune system engagement. The availability of toripalimab in India emphasizes Dr. Reddy’s commitment to increasing access to cutting-edge cancer therapies in underserved regions.

Which Leading Companies Dominate The Cancer Therapy Market Share?

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cancer-therapy-global-market-report

Which Region Currently Holds The Largest Share Of The Cancer Therapy Market?

North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cancer Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24492&type=smp

Browse Through More Reports Similar to the Global Cancer Therapy Market 2025, By The Business Research Company

Oncology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report

Blood Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-drug-discovery-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Cancer Therapy Market Heading Into 2029?

In recent times, the size of the cancer therapy market has expanded swiftly. The market which is expected to be $190.44 billion in 2024, is projected to escalate to $210.44 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%. Factors such as the increased global occurrence of cancer, the growth in the uptake of chemotherapy procedures, rising consciousness about early detection of cancer, the augmented presence of oncology experts, and the improved access to hospital-oriented treatment services have contributed to the growth during the historical period.

In the coming years, the cancer therapy market is predicted to witness significant expansion. It is projected to reach a whopping $310.85 billion in 2029, increasing at a compound annual growth rate (CAGR) of 10.2%. The surge during the forecast period is attributable to the rising demand for custom-tailored cancer treatments, an amplified focus on outpatient cancer care, increased use of immunotherapy, wider access to healthcare in developing economies, and the growing prevalence of lifestyle-related cancers. Key trends for the forecast period include technological breakthroughs in cancer detection, advancements in targeted drug delivery techniques, augmented investment in biologics’ research and development, adoption of AI in devising treatment plans, and advancements in less invasive cancer surgery procedures.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24492&type=smp

Which Factors Are Pushing The Cancer Therapy Market Forward?

The escalating incidence of cancer is projected to stimulate the expansion of the cancer therapy market in the future. Cancer constitutes a collection of illnesses marked by unchecked growth and dissemination of unusual cells in the body. The rise in cancer is predominantly attributable to enhanced exposure to environmental carcinogens like pollution and tobacco smoke. Cancer therapy is instrumental in controlling the escalating incidence of cancer by handling current cases, enhancing survival rates, and curtailing disease progression. For example, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, in February 2024, the global cancer incidence is predicted to surpass 35 million new cases by 2050, a 77% rise from the projected 20 million cases registered in 2022. Consequently, the escalating incidence of cancer is propelling the cancer therapy market.

Which Segment Held The Largest Share In The Cancer Therapy Market In 2025?

The cancer therapy market covered in this report is segmented –

1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types

2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types

3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers

Subsegment:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs

2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents

3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies

4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)

5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy

How Are Key Trends Driving Expansion In The Cancer Therapy Industry?

Leading companies in the cancer therapy market are prioritizing the development of innovative therapies, such as immuno-oncology drugs, to improve treatment outcomes by using the body’s immune system to identify and eliminate cancer cells. Immuno-oncology drugs, a type of cancer treatment, work by boosting or enhancing the body’s immune system to more effectively recognize and attack cancer cells. For example, in December 2024, Toripalimab, the first and only immuno-oncology medication approved for nasopharyngeal cancer treatment, was launched in India by Dr. Reddy’s Laboratories Ltd., a pharmaceutical company based in India. This introduction opens up a new, customized treatment channel for those affected by this uncommon, highly aggressive cancer, with the potential to improve results via advanced immune system activation. Dr. Reddy’s has shown its dedication to broadening access to pioneering cancer therapies in underprivileged areas with the availability of toripalimab in India.

Which Organizations Are Driving Progress In The Cancer Therapy Industry?

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-therapy-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Cancer Therapy Industry?

North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24492&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Cancer Therapy Market Growth in 2025?

The market size of cancer therapy has witnessed significant expansion recently. A rise from $190.44 billion in 2024 to $210.44 billion in 2025 with a compound annual growth rate (CAGR) of 10.5% is anticipated. Factors contributing to this growth in the historic period include an increase in global cancer incidents, a surge in the usage of chemotherapy procedures, greater consciousness about early detection of cancer, a growing number of oncology professionals, and enhanced access to treatments at hospitals.

What Is the Forecast for the Cancer Therapy Market Size Through 2029?

The market size for cancer therapy is projected to experience accelerated expansion in the years to come, reaching a value of $310.85 billion by 2029 with a compound annual growth rate (CAGR) of 10.2%. The predicted rise during the forecast period can be associated with an increasing requirement for personalized cancer treatments, amplified emphasis on outpatient cancer treatment, a surge in the acceptance of immunotherapy, more accessible healthcare in emerging economies, and an uptick in cancers related to lifestyle. Key trends for the forecast period comprise technological breakthroughs in cancer diagnostics, advancements in targeted drug delivery, investment in the research and development of biologics, the progression of AI-based treatment planning, and innovations in minimally invasive cancer surgeries.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24492&type=smp

What are the Key Market Players in Cancer Therapy Market and How They’re Evolving?

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.

What Are the Primary Growth Drivers in the Cancer Therapy Market?

The growth of the cancer therapy market is anticipated to be spurred by the escalating rates of cancer worldwide. Cancer, defined as a collection of diseases marked by the rampant growth and proliferation of irregular cells in the organism, is predominantly attributed to heightened exposure to environmental carcinogens, including pollution and tobacco smoke. The critical function of cancer therapy is to manage the escalating instances of cancer by treating those affected, enhancing survival rates and minimizing disease advancement. For instance, the Switzerland-based intergovernmental body, the World Health Organization (WHO), predicted that by 2050, the global cancer incidence is anticipated to surpass 35 million new cases. This number represents a dramatic 77% increase from the projected 20 million cases in 2022. Consequently, the surging instances of cancer are fuelling the expansion of the cancer therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24492&type=smp

What Are the Leading Segments in the Global Cancer Therapy Industry?

The cancer therapy market covered in this report is segmented –

1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types

2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types

3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers

Subsegment:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs

2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents

3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies

4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)

5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy

What Are the Key Market Trends in the Cancer Therapy Industry?

Leading businesses in the cancer therapy market are focusing their efforts on the development of innovative treatments, such as immuno-oncology medications, with the aim of enhancing the effectiveness of cancer treatment. These medications work by leveraging the power of the body’s immune system to identify and eliminate cancerous cells. Immuno-oncology drugs promote the immune system’s ability to target and eliminate cancer cells more efficiently. In December 2024, an immuno-oncology drug named Toripalimab was launched in India by Dr. Reddy’s Laboratories Ltd., a well-known Indian pharmaceutical firm. Toripalimab, the first and only medication of its kind authorized to treat nasopharyngeal cancer, offers a new, focused treatment option for those fighting this rare and aggressive type of cancer. By engaging the immune system, it could potentially enhance patient outcomes. The launch of toripalimab in India highlights Dr. Reddy’s dedication to increase the availability of advanced cancer treatments in regions that lack such services.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-therapy-global-market-report

What Is the Regional Outlook for the Cancer Therapy Market?

North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24492

This Report Delivers Insight On:

1. How big is the cancer therapy market, and how is it changing globally?

2. Who are the major companies in the cancer therapy market, and how are they performing?

3. What are the key opportunities and risks in the cancer therapy market right now?

4. Which products or customer segments are growing the most in the cancer therapy market?

5. What factors are helping or slowing down the growth of the cancer therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model